1 / 3

Asia Pacific Nuclear Medicine Diagnostics Market quickly expanding to reach USD 3.86 billion by 2018-2023

The emerging market tendency will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness fastest growth compared to SPECT imaging as it delivers higher resolution images and the technetium-99m is forcing industry to look for alternative diagnostic procedures.

kumarvasa
Télécharger la présentation

Asia Pacific Nuclear Medicine Diagnostics Market quickly expanding to reach USD 3.86 billion by 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Asia Pacific Nuclear Medicine Diagnostics Market is projected to be reach USD 3.86 Billion by 2023 Overview: Nuclear drugs are a field of scientific expertise related to the usefulness of radioactive materials in the prognosis and treatment of the disease. The nuclear medical drug in a sense is radiology performed at the output or & quot; give up radiology & quot; Because it records the radiation emitted by the body near the radiation it is generated by means of external objects such as X- rays. View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-nuclear- medicine-diagnostics-market-126/request-sample Asia Pacific Nuclear Medicine Diagnostics Market size was around USD 2.01 billion in 2018. It is expected to grow at a CAGR of 13.9% to reach USD 3.86 billion by 2023. Drivers and Restraints: Increasing awareness among people about radiopharmaceuticals, increasing usage of SPECT and PET in medical diagnostics, ready availability of radiopharmaceuticals, growing risk of fatal cancer and other chronic diseases. However high cost for the treatment and strict government regulations are the factors hindering the market. To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-nuclear- medicine-diagnostics-market-126/ Geographic Segmentation The Asia Pacific Nuclear Medicine Diagnostics market has geographically segmented into China, India, Japan, South Korea, and Australia. Asia’s market is the fastest growing CAGR market compared to other regions.

  2. Get your customized report:https://www.marketdataforecast.com/market-reports/asia-pacific- nuclear-medicine-diagnostics-market-126/customize-report Major companies in the market are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc. Scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™

  3. Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626

More Related